The compound of formula (IA), (IB) or (IC.1) ** Formula ** in which A indicates a bond, -CH2-, -CH2CH2- or -CH2-O-, R1 is selected from the group that It consists of hydrogen, C1-6 alkyl, C1-4-SO2- alkyl, C1-4-NH-CO- alkyl, H2N-CO-, H2N-C1-4- alkyl, H2N-C1-4-CO- alkyl, H2 C1-4-NH-CO- alkyl, Phenyl-CO-, Phenyl-CH2-CO-, Phenyl-CH2-, C1-6-CO- alkyl, C1-6 alkyl -O- C1-4-CO- alkyl, (CH3) 2N-C1-4 alkyl-, (CH3) 2N-C1-4 alkyl-NH-CO-, (CH3) 3N + -C 1-4 alkyl-NH-CO-, (CH3) N + -C 1-4 alkyl -N (C1-4 alkyl) -CO-, (CH3) 3N + -C2-4 alkyl, (CH3) 3N + -C 1-4 alkyl-CO-, H2N-C (NH) -NH-C1-6 alkyl- NH-CO-, C1-6-O-CO- alkyl, C1-6-O-CO-C1-4 alkyl, C1-6-O-CO-C1-4-CO- alkyl, C1- alkyl 6-O-CO-C 1-4 alkyl-NHCO-, C 1-6 alkyl-O-CO-NH-C 1-4 alkyl, C 1-6 alkyl-O-CO-NH-C 1-4 alkyl- C1-6-O-CO-NH alkyl C1-4 alkyl-NHCO-, HOCO C1-4 alkyl-, HOCO-C1-4 alkyl-CO-, HOCO-C1-4 alkyl-NH-CO-, H2N-CNH - and H2NC (NH) NH-C1-6-CO- alkyl, or R1 is selected from a group of formulas enu Next, (c1) to (c5): ** Formula ** R1b is C1-4 alkyl, R1s indicates C1-6 alkyl, X- indicates any anion that forms a pharmaceutically acceptable salt, L indicates a bridged group - CO-NH-C2-6-NH-CO- alkyl, -CO-C 1-6 alkyl-CO- or -C2-6 alkyl, forming a compound of formula (IC.1), whereby the molecular entities of formula (IC.1) connected by L may be identical or different, R2, R3, R4, R6, R7, R2a, R3a, R4a, R6a and R7a indicate hydrogen and the pharmacologically acceptable acid addition salts thereof.El compuesto de fórmula (IA), (IB) o (IC.1)**Fórmula** en la que A indica un enlace, -CH2-, -CH2CH2- o -CH2-O-, R1 se selecciona del grupo que consiste en hidrógeno, alquilo C1-6, alquilo C1-4-SO2-, alquilo C1-4-NH-CO-, H2N-CO-, H2N-alquilo C1-4-, H2N-alquilo C1-4-CO-, H2Nalquilo C1-4-NH-CO-, Fenil-CO-, Fenil-CH2-CO-, Fenil-CH2-, alquilo C1-6-CO-, alquilo C1-6 -O- alquilo C1-4-CO-, (CH3)2N-alquilo C1-4-, (CH3)2N-alquilo C1-4-NH-CO-, (CH3)3N+-alquilo C1-4-NH-CO-, (CH3)N+-alquilo C1-4-N(alquilo C1- 4)-CO-, (CH3)3N+-alquilo C2-4-, (CH3)3N+-a
